Update on Keratinocyte Carcinomas.

Keratinocyte Carcinomas Squamous-cell and basal-cell carcinomas of the skin are increasing in frequency. Basal-cell carcinomas are responsive to inhibition of the hedgehog pathway; squamous-cell ca...

[1]  P. Uribe,et al.  High-risk cutaneous squamous cell carcinoma and the emerging role of sentinel lymph node biopsy: A literature review. , 2015, Journal of the American Academy of Dermatology.

[2]  J. Strasswimmer,et al.  Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma: A Systematic Review and Pooled Analysis of Interventional Studies. , 2016, JAMA dermatology.

[3]  Brian O'Sullivan,et al.  Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.

[4]  R. Dellavalle,et al.  It's time for "keratinocyte carcinoma" to replace the term "nonmelanoma skin cancer". , 2015, Journal of the American Academy of Dermatology.

[5]  Jean Cadet,et al.  DNA base damage by reactive oxygen species, oxidizing agents, and UV radiation. , 2013, Cold Spring Harbor perspectives in biology.

[6]  J. Leonardi-Bee,et al.  A systematic review of worldwide incidence of nonmelanoma skin cancer , 2012, The British journal of dermatology.

[7]  S. Arron,et al.  NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis , 2014, The Journal of investigative dermatology.

[8]  H. Williams,et al.  Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial. , 2017, The Journal of investigative dermatology.

[9]  K. Sarin,et al.  Genetic diseases associated with an increased risk of skin cancer development in childhood , 2017, Current opinion in pediatrics.

[10]  Carmen D Dirksen,et al.  Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up. , 2014, European journal of cancer.

[11]  A. Qureshi,et al.  Basal-cell carcinoma incidence and associated risk factors in U.S. women and men. , 2013, American journal of epidemiology.

[12]  Aparna Bhaduri,et al.  Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous squamous cell carcinoma , 2014, Nature Genetics.

[13]  J. Califano,et al.  Comparison of Tumor Classifications for Cutaneous Squamous Cell Carcinoma of the Head and Neck in the 7th vs 8th Edition of the AJCC Cancer Staging Manual , 2017, JAMA dermatology.

[14]  G. Daniels,et al.  Rescue therapy with anti‐programmed cell death protein 1 inhibitors of advanced cutaneous squamous cell carcinoma and basosquamous carcinoma: preliminary experience in five cases , 2016, The British journal of dermatology.

[15]  D. Rischin,et al.  Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Jean Y. Tang,et al.  Smoothened variants explain the majority of drug resistance in basal cell carcinoma. , 2015, Cancer cell.

[17]  T. Olencki,et al.  Guidelines of care for the management of basal cell carcinoma. , 2018, Journal of the American Academy of Dermatology.

[18]  R. Scolyer,et al.  A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. , 2015, The New England journal of medicine.

[19]  A. Klassen,et al.  Patient experiences and outcomes following facial skin cancer surgery: A qualitative study , 2016, The Australasian journal of dermatology.

[20]  M. Murad,et al.  Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis. , 2016, JAMA dermatology.

[21]  F. Simpson,et al.  Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  Matthew M. Johnson,et al.  Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study. , 2013, JAMA dermatology.

[23]  Fan Xiang,et al.  Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012: empirical relationships. , 2014, JAMA dermatology.

[24]  A. Hauschild,et al.  PD‐1 Blockade with Cemiplimab in Advanced Cutaneous Squamous‐Cell Carcinoma , 2018, The New England journal of medicine.

[25]  C. Reddy,et al.  A multi‐institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck , 2017, Cancer.

[26]  Gail M. Williams,et al.  Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial , 1999, The Lancet.

[27]  C. Elmets,et al.  Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond , 2017, Molecular carcinogenesis.

[28]  A. Hauschild,et al.  Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study , 2017, BMC Cancer.

[29]  E. Genden,et al.  Cutaneous Squamous Cell Carcinoma of the Head and Neck , 2011, Journal of skin cancer.

[30]  A. Qureshi,et al.  Geographical Variation in Residence and Risk of Multiple Nonmelanoma Skin Cancers in US Women and Men , 2012, Photochemistry and photobiology.

[31]  C. Schmults,et al.  Clinical and Incidental Perineural Invasion of Cutaneous Squamous Cell Carcinoma: A Systematic Review and Pooled Analysis of Outcomes Data , 2017, JAMA dermatology.

[32]  W. Hwang,et al.  Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. , 2013, JAMA dermatology.

[33]  C. Garbe,et al.  Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort Study. , 2017, The Journal of investigative dermatology.

[34]  S Kamen,et al.  The task force. , 1976, Journal of hospital dental practice.

[35]  A. Qureshi,et al.  Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. , 2013, JAMA dermatology.

[36]  T. Olencki,et al.  Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors , 2017, Cancer.

[37]  S. Dusza,et al.  Comorbidity scores associated with limited life expectancy in the very elderly with nonmelanoma skin cancer , 2017, Journal of the American Academy of Dermatology.

[38]  J. Roodenburg,et al.  Multivariate analysis of potential risk factors for lymph node metastasis in patients with cutaneous squamous cell carcinoma of the head and neck. , 2016, Journal of the American Academy of Dermatology.

[39]  R. Dummer,et al.  Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[40]  A. Toland,et al.  Epidemiology of keratinocyte carcinomas after organ transplantation , 2017, The British journal of dermatology.

[41]  B. Mittal,et al.  Guidelines of care for the management of cutaneous squamous cell carcinoma. , 2018, Journal of the American Academy of Dermatology.

[42]  S. Feldman,et al.  Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. , 2015, JAMA dermatology.

[43]  Grant D. Huang,et al.  Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial , 2018, JAMA dermatology.

[44]  Jean Y. Tang,et al.  Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors. , 2016, Journal of the American Academy of Dermatology.

[45]  Murad Alam,et al.  Functionality of Patients 75 Years and Older Undergoing Mohs Micrographic Surgery: A Multicenter Study , 2017, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[46]  M. Chren,et al.  Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma. , 2015, JAMA dermatology.

[47]  J. Dillner,et al.  Prospective study of genital human papillomaviruses and nonmelanoma skin cancer , 2013, International journal of cancer.

[48]  M. Chren,et al.  Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer. , 2013, JAMA internal medicine.

[49]  C. Bokemeyer,et al.  Platinum-based chemotherapy plus cetuximab in head and neck cancer. , 2008, The New England journal of medicine.

[50]  C. Schmults,et al.  Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors. , 2018, Journal of the American Academy of Dermatology.

[51]  A. Marghoob,et al.  Reflectance confocal microscopy of skin in vivo: From bench to bedside , 2017, Lasers in surgery and medicine.

[52]  K. Nehal,et al.  FACE‐Q Skin Cancer Module for measuring patient‐reported outcomes following facial skin cancer surgery , 2018, The British journal of dermatology.

[53]  C. Proby,et al.  Known and potential new risk factors for skin cancer in European populations: a multicentre case–control study , 2012, The British journal of dermatology.

[54]  R. Roenigk,et al.  A new evidence‐based risk stratification system for cutaneous squamous cell carcinoma into low, intermediate, and high risk groups with implications for management , 2018, Journal of the American Academy of Dermatology.

[55]  D. Hunter,et al.  Use of tanning beds and incidence of skin cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  C. Schmults,et al.  Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging. , 2018, Journal of the American Academy of Dermatology.

[57]  Sebastian Thrun,et al.  Dermatologist-level classification of skin cancer with deep neural networks , 2017, Nature.

[58]  A. Mutirangura,et al.  Squamous cell carcinoma of head and neck. , 1997, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[59]  H. Moffet,et al.  Trends in Basal Cell Carcinoma Incidence and Identification of High-Risk Subgroups, 1998-2012. , 2015, JAMA dermatology.

[60]  S. Strom,et al.  Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[61]  K. Aben,et al.  The Epidemiology and Clinicopathological Features of Basal Cell Carcinoma in Patients 80 Years and Older: A Systematic Review , 2017, JAMA dermatology.

[62]  E. M. Warton,et al.  HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. , 2013, Journal of the National Cancer Institute.

[63]  M. Weinstock,et al.  Trends of Keratinocyte Carcinoma Mortality Rates in the United States as Reported on Death Certificates, 1999 Through 2010 , 2014, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[64]  M. Asgari,et al.  Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load , 2017, JAMA dermatology.

[65]  K. Nehal,et al.  A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population. , 2013, Journal of the American Academy of Dermatology.

[66]  A. Qureshi,et al.  Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  G. Guy,et al.  Surgeon General’s Call to Action to Prevent Skin Cancer , 2014, Morbidity and Mortality Weekly Report.

[68]  K.,et al.  Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. , 2015, American journal of preventive medicine.

[69]  Erica H Lee,et al.  Optimizing Informed Decision Making for Basal Cell Carcinoma in Patients 85 Years or Older. , 2015, JAMA dermatology.

[70]  David R Bickers,et al.  Sonic hedgehog signaling in Basal cell nevus syndrome. , 2014, Cancer research.

[71]  A. Bader,et al.  The intensity and variation of surgical care at the end of life: a retrospective cohort study , 2011, The Lancet.

[72]  C. Rudin,et al.  Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma. , 2015, Cancer cell.

[73]  Curtis R. Pickering,et al.  Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma , 2014, Clinical Cancer Research.

[74]  A. Qureshi,et al.  History of Keratinocyte Carcinoma and Risk of Melanoma: A Prospective Cohort Study , 2017, Journal of the National Cancer Institute.

[75]  Henry W. Lim,et al.  Tanning lamps: health effects and reclassification by the Food and Drug Administration. , 2015, Journal of the American Academy of Dermatology.